Alteration of CD8+ CD45RC[int/neg] regulatory T cells functions in Multiple Sclerosis and correlates with disease severity - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Conference Poster Year :

Alteration of CD8+ CD45RC[int/neg] regulatory T cells functions in Multiple Sclerosis and correlates with disease severity

Abstract

Autoimmune diseases can develop following pathological activation of autoreactive effector cells and/or, alternatively, after weakening of self-protective regulatory mechanisms. Most of the studies have focused on CD4+ Tregs and the role of CD8+ Tregs in Multiple Sclerosis (MS) remains largely unexplored. We previously reported the suppressive properties of rat and human CD8+CD45RCint/neg Treg cells, expressing Foxp3 and acting through IFNg, TGFb and IL34 cytokines (Guillonneau, JCI, 2007; Bézie, JCI, 2015, Bézie, Front. Immunol., 2018). Thus, their potency of suppression make them strong candidates of disruptive immune tolerance, especially in MS where CD8+ T cells play a major role. Thus, the overreaching goal of this study is to define the role of CD8+ regulatory T cell in MS pathogenesis.
Fichier principal
Vignette du fichier
Poster ECTRIMS Naïl Benallegue pour impression (1).pdf (684.63 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

inserm-02159755 , version 1 (19-06-2019)

Identifiers

  • HAL Id : inserm-02159755 , version 1

Cite

Naïl Benallegue, Bryan Nicol, Séverine Bézie, Hadrien Regue, Nadège Vimont, et al.. Alteration of CD8+ CD45RC[int/neg] regulatory T cells functions in Multiple Sclerosis and correlates with disease severity. ECTRIMS 2018 (34th congress of the european committee for treatment and research in Multiple Sclerosis), Oct 2018, Berlin, Germany. ⟨inserm-02159755⟩
77 View
79 Download

Share

Gmail Facebook Twitter LinkedIn More